AUPH insider buying
Aurinia Pharmaceuticals Inc.
Every qualifying open-market purchase of AUPH reported to the SEC on Form 4, parsed directly from the filings and linked back to the source on EDGAR. No buying cluster — two or more distinct insiders inside a rolling window — has been detected in AUPH yet; if one forms, it appears here (and hits our alert subscribers in real time).
All notable open-market buys in AUPH
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Jun 2, 2026 | Director, Chief Executive Officer, 10% Owner | 206,005 | $15.28 | $3.1M | SEC ↗ |
| Jun 1, 2026 | Director, Chief Executive Officer, 10% Owner | 343,521 | $15.28 | $5.2M | SEC ↗ |
| May 29, 2026 | Director, Chief Executive Officer, 10% Owner | 262,682 | $15.31 | $4.0M | SEC ↗ |
| Mar 3, 2026 | Director | 184,208 | $14.22 | $2.6M | SEC ↗ |
| Mar 2, 2026 | Director | 115,792 | $14.21 | $1.6M | SEC ↗ |
| Mar 2, 2026 | Director | 83,561 | $14.33 | $1.2M | SEC ↗ |
| Feb 27, 2026 | Director | 300,000 | $13.90 | $4.2M | SEC ↗ |
| Feb 27, 2026 | Director | 214,839 | $14.12 | $3.0M | SEC ↗ |
| Aug 5, 2025 | Director | 200,000 | $11.68 | $2.3M | SEC ↗ |
| Aug 4, 2025 | Director | 100,000 | $11.34 | $1.1M | SEC ↗ |
| Aug 1, 2025 | Director | 1,000,000 | $10.12 | $10.1M | SEC ↗ |
| Mar 4, 2025 | Director | 500,000 | $7.92 | $4.0M | SEC ↗ |
| Mar 4, 2025 | Director | 148,038 | $8.00 | $1.2M | SEC ↗ |
| Mar 4, 2025 | Director | 100,000 | $8.09 | $809.0K | SEC ↗ |
| Mar 3, 2025 | Director | 351,962 | $8.02 | $2.8M | SEC ↗ |
| Mar 3, 2025 | Director | 100,720 | $7.97 | $802.7K | SEC ↗ |
| Feb 28, 2025 | Director | 399,280 | $7.85 | $3.1M | SEC ↗ |
| Dec 9, 2024 | Director | 500,000 | $9.09 | $4.5M | SEC ↗ |
| Dec 6, 2024 | Director | 400,000 | $9.01 | $3.6M | SEC ↗ |
| Dec 5, 2024 | Director | 300,000 | $8.91 | $2.7M | SEC ↗ |
AUPH insider buying — FAQ
- Are insiders buying AUPH stock?
- 1 insider has bought AUPH (Aurinia Pharmaceuticals Inc.) on the open market, most recently on Jun 2, 2026. No cluster buy — two or more distinct insiders within a rolling window — has been detected yet.
- How much AUPH stock have insiders bought?
- Insiders have bought a combined $62.2M of AUPH across 20 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in AUPH?
- A cluster buy is two or more distinct Aurinia Pharmaceuticals Inc. insiders — officers, directors, or 10% owners — each buying AUPH on the open market within a rolling window. None has been detected in AUPH yet.
- Where does this AUPH insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in AUPH
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy AUPH within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding AUPH.